190 related articles for article (PubMed ID: 24155143)
1. A multidisciplinary team approach to the management of patients with suspected or diagnosed invasive fungal disease.
Ben-Ami R; Halaburda K; Klyasova G; Metan G; Torosian T; Akova M
J Antimicrob Chemother; 2013 Nov; 68 Suppl 3():iii25-33. PubMed ID: 24155143
[TBL] [Abstract][Full Text] [Related]
2. Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects.
Akan H; Antia VP; Kouba M; Sinkó J; Tănase AD; Vrhovac R; Herbrecht R
J Antimicrob Chemother; 2013 Nov; 68 Suppl 3():iii5-16. PubMed ID: 24155144
[TBL] [Abstract][Full Text] [Related]
3. A multidisciplinary approach to managing invasive fungal disease. Introduction and aims.
Donnelly JP
J Antimicrob Chemother; 2013 Nov; 68 Suppl 3():iii3-4. PubMed ID: 24319773
[No Abstract] [Full Text] [Related]
4. A multidisciplinary approach to managing invasive fungal disease. Preface.
Ullmann AJ; Johnson A
J Antimicrob Chemother; 2013 Nov; 68 Suppl 3():i1. PubMed ID: 24319774
[No Abstract] [Full Text] [Related]
5. Triggers for driving treatment of at-risk patients with invasive fungal disease.
Drgona L; Colita A; Klimko N; Rahav G; Ozcan MA; Donnelly JP
J Antimicrob Chemother; 2013 Nov; 68 Suppl 3():iii17-iii24. PubMed ID: 24155142
[TBL] [Abstract][Full Text] [Related]
6. Antifungal prophylaxis: why, what and how?
Lyon S
Future Microbiol; 2016; 11(1):11-5. PubMed ID: 26674314
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
Girmenia C; Barosi G; Aversa F; Bacigalupo A; Barbui T; Baronciani D; Bosi A; Candoni A; Locasciulli A; Locatelli F; Menichetti F; Musso M; Viscoli C; Rambaldi A
Clin Infect Dis; 2009 Oct; 49(8):1226-36. PubMed ID: 19772390
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in antifungal prevention and treatment.
Groll AH; Tragiannidis A
Semin Hematol; 2009 Jul; 46(3):212-29. PubMed ID: 19549575
[TBL] [Abstract][Full Text] [Related]
9. Pre-emptive diagnosis and treatment of fungal infections--evaluation of a single-centre policy.
Schneider T; Halter J; Heim D; Passweg J; Stern M; Tichelli A; Weisser M; Gerull S
Clin Microbiol Infect; 2012 Feb; 18(2):189-94. PubMed ID: 21729194
[TBL] [Abstract][Full Text] [Related]
10. Posaconazole prophylaxis--impact on incidence of invasive fungal disease and antifungal treatment in haematological patients.
Peterson L; Ostermann J; Rieger H; Ostermann H; Rieger CT
Mycoses; 2013 Nov; 56(6):651-8. PubMed ID: 23710592
[TBL] [Abstract][Full Text] [Related]
11. Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation.
Michallet M; Ito JI
J Clin Oncol; 2009 Jul; 27(20):3398-409. PubMed ID: 19487382
[TBL] [Abstract][Full Text] [Related]
12. [Fungal infection in hematopoietic stem cell transplantation].
Taniguchi S
Rinsho Ketsueki; 2008 Oct; 49(10):1349-57. PubMed ID: 18833919
[No Abstract] [Full Text] [Related]
13. Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation.
Herbrecht R; Caillot D; Cordonnier C; Auvrignon A; Thiébaut A; Brethon B; Michallet M; Mahlaoui N; Bertrand Y; Preziosi P; Ruiz F; Gorin NC; Gangneux JP
J Antimicrob Chemother; 2012 Nov; 67(11):2731-8. PubMed ID: 22850692
[TBL] [Abstract][Full Text] [Related]
14. Current practice of antifungal prophylaxis and treatment in immunocompromised children and adults with malignancies: a single centre approach.
Lehrnbecher T; Mousset S; Sörensen J; Böhme A
Mycoses; 2009 Mar; 52(2):107-17. PubMed ID: 18983431
[TBL] [Abstract][Full Text] [Related]
15. Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?
Rogers TR; Slavin MA; Donnelly JP
Br J Haematol; 2011 Jun; 153(6):681-97. PubMed ID: 21504422
[TBL] [Abstract][Full Text] [Related]
16. Secondary antifungal prophylaxis in hematological malignancy patients with previous invasive fungal disease: a retrospective analysis.
Liu M; Li Y; Zhang Y; Zhao X; Zhai B; Zhang Q; Wang L; Zhao Y; Li H; Wang Q; Gao C; Huang W; Yu L
PLoS One; 2014; 9(12):e115461. PubMed ID: 25531544
[TBL] [Abstract][Full Text] [Related]
17. A practical critique of antifungal treatment guidelines for haemato-oncologists.
Agrawal S; Jones B; Barnes R; Kibbler C; Millen M; Ashcroft M; Jain S; Last A; Lewis D; Lewis T; Patel M; Pagliuca A
Crit Rev Microbiol; 2012 Aug; 38(3):203-16. PubMed ID: 22324737
[TBL] [Abstract][Full Text] [Related]
18. Safety, clinical effectiveness and trough plasma concentrations of intravenous posaconazole in patients with haematological malignancies and/or undergoing allogeneic haematopoietic stem cell transplantation: off-trial experience.
Jeong W; Haywood P; Shanmuganathan N; Lindsay J; Urbancic K; Ananda-Rajah MR; Chen SC; Bajel A; Ritchie D; Grigg A; Seymour JF; Peleg AY; Kong DC; Slavin MA
J Antimicrob Chemother; 2016 Dec; 71(12):3540-3547. PubMed ID: 27521358
[TBL] [Abstract][Full Text] [Related]
19. [Malignant blood diseases and fungal infection: what does mycology provide in the year 2001?].
del Palacio A; Cuétara MS; Ortiz MC
Enferm Infecc Microbiol Clin; 2001; 19(7):293-5. PubMed ID: 11747786
[No Abstract] [Full Text] [Related]
20. Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registry.
Vehreschild JJ; Sieniawski M; Reuter S; Arenz D; Reichert D; Maertens J; Böhme A; Silling G; Martino R; Maschmeyer G; Rüping MJ; Ullmann AJ; Cornely OA
Int J Antimicrob Agents; 2009 Nov; 34(5):446-50. PubMed ID: 19700265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
